Biochemical analysis of cross‐feeding behaviour between two common gut commensals when cultivated on plant‐derived arabinogalactan by Munoz, Jose et al.
Northumbria Research Link
Citation:  Munoz,  Jose,  James,  Kieran,  Bottacini,  Francesca  and  Van  Sinderen,  Douwe  (2020) 
Biochemical  analysis  of  cross feeding  behaviour  between  two  common  gut  commensals  when‐  
cultivated on plant derived arabinogalactan. Microbial Biotechnology. ISSN 1751-7915 (In Press) ‐
Published by: Wiley-Blackwell
URL: https://doi.org/10.1111/1751-7915.13577 <https://doi.org/10.1111/1751-7915.13577>
This  version  was  downloaded  from  Northumbria  Research  Link: 
http://nrl.northumbria.ac.uk/id/eprint/43051/
Northumbria University has developed Northumbria Research Link (NRL) to enable users to access 
the University’s research output. Copyright © and moral rights for items on NRL are retained by the 
individual author(s) and/or other copyright owners.  Single copies of full items can be reproduced, 
displayed or performed, and given to third parties in any format or medium for personal research or 
study, educational, or not-for-profit purposes without prior permission or charge, provided the authors, 
title and full bibliographic details are given, as well as a hyperlink and/or URL to the original metadata 
page. The content must not be changed in any way. Full items must not be sold commercially in any  
format or medium without formal permission of the copyright holder.  The full policy is available online: 
http://nrl.northumbria.ac.uk/pol  i cies.html  
This  document  may differ  from the  final,  published version of  the research  and has been made 
available online in accordance with publisher policies. To read and/or cite from the published version 
of the research, please visit the publisher’s website (a subscription may be required.)
                        

Biochemical analysis of cross-feeding behaviour
between two common gut commensals when cultivated
on plant-derived arabinogalactan
Jose Munoz1* Kieran James,2 Francesca
Bottacini2 and Douwe Van Sinderen2
1Microbial Enzymology Group, Department of Applied
Sciences, Northumbria University, Newcastle Upon
Tyne, NE1 8ST,UK.
2School of Microbiology & APC Microbiome Ireland,
University College Cork, Ireland University College Cork,
Cork, Ireland.
Summary
In this paper, we reveal and characterize cross-feeding
behaviour between the common gut commensal Bac-
teroides cellulosilyticus (Baccell) and certain bifi-
dobacterial strains, including Bifidobacterium breve
UCC2003, when grown on a medium containing Larch
WoodArabinogalactan (LW-AG). We furthermore show
that cross-feeding is dependent on the release of b-1,3-
galacto-di/trisaccharides (b-1,3-GOS), and identified
that the bga gene cluster ofB. breveUCC2003 allows b-
1,3-GOS metabolism. The product of bgaB is pre-
sumed to be responsible for the import of b-1,3-GOS,
while the bgaA gene product, a glycoside hydrolase
family 2 member, was shown to hydrolyse both b-1,3-
galactobiose and b-1,3-galactotriose into galactose
monomers. This study advances our understanding of
strain-specific syntrophic interactions between two
glycan degraders in the human gut in the presence of
AG-type dietary polysaccharides.
Introduction
Arabinogalactans (AGs) represent plant cell wall-associ-
ated proteoglycans which are widely distributed in the
plant kingdom (Fujita et al., 2019). The carbohydrate
component of AGs is composed of a b-1,3-galactan
backbone with b-1,6-galactan side chains which typically
contain further decorations, together representing over
90% of the total AG mass. These decorations, which
include, among others, L-arabinose, L-rhamnose, L-fu-
cose and D-(methyl)-glucuronic acid, are highly variable
in length, linkage and sugar moiety (Ponder and
Richards, 1997; Fujita et al., 2019). The glycan compo-
nent of such AGs will resist digestion by human
enzymes to become available to the gut microbiota as
fermentable substrates. Because of their complexity, it is
likely that only a small number of gut bacteria are able
to access the glycan component of AG either directly or
indirectly by means of syntrophic interactions. If (some
of) these AG-metabolizing microbiota members convey
health benefits to their host, such carbohydrates may be
considered prebiotic (Harris et al., 2019). Some AGs,
exemplified by the glycan isolated from Larch Wood, are
considered simpler in their chemical structure, whereas
others, such as Gum Arabic from the Acacia Senegal
tree, are considered more complex (Cartmell et al.,
2018). The latter AG (referred to as GA-AG) is used
extensively in the food industry as emulsifier (Mu~noz-
Mu~noz et al., 2017), while the former has been commer-
cialized as a fibre with purported prebiotic activity (Fujita
et al., 2014). The common use of AGs as food additives,
and their ubiquitous presence in plant species, explains
why these glycans constitute common components of
the human diet.
The human gut microbiota (HGM) is an important con-
tributor to human health where it supports and enhances
the physiology of its host (Ndeh et al., 2020; Glowacki
et al., 2020). The major nutrients available to this diverse
microbial assembly are complex host- and diet-derived
glycans (Wang et al., 2019; Ndeh et al., 2020; Glowacki
et al., 2020). Consistent with the importance of glycan
metabolism, genomic data revealed that members of the
HGM encode a very large number of carbohydrate-active
enzymes (CAZymes), primarily glycoside hydrolases
(GHs) and polysaccharide lyases (PLs). These enzymes
are grouped into sequence-related families and depos-
ited in the CAZy database (Terrapon et al., 2018). The
structural fold, catalytic apparatus and mechanism are
conserved within families, while substrate specificity may
vary among members of a given family, exemplified by
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GH members of the GH5 family, or can be invariant as
in those belonging to GH10 (Labourel et al., 2016). As
an example of the glycan-degrading abilities of a mem-
ber of the HGM, the genome of Bacteroides thetaio-
taomicron is predicted to encode 288 GHs that belong to
57 families (Lapebie et al., 2019). GHs hydrolyse glyco-
sidic bonds through an acid/base-assisted mechanism
deploying either double or single displacement catalysis,
leading to the retention or inversion of the anomeric con-
figuration, respectively. In nearly all of the 166 GH fami-
lies described in the CAZY database, the catalytic
apparatus involves two carboxylate residues being either
aspartic or glutamic acid (Terrapon et al., 2018).
All sequenced Bacteroides genomes have been
shown to harbour so-called polysaccharide utilization loci
(PULs), which consist of clustered and co-regulated
genes encoding CAZymes, glycan transporters and sen-
sors that control transcription of the cognate locus (Foley
et al., 2016; Glenwright, et al., 2017). Generally, a cell
surface-located GH or PL initiates glycan degradation.
The oligosaccharides that are in this way generated are
imported into the periplasm and then further depolymer-
ized by periplasmic GHs and/or PLs into monosaccha-
rides, which are then internalized into the cytoplasm and
used as energy and carbon sources (Ndeh, et al., 2017).
Transcriptomic data identified two Ba. thetaiotaomicron
PULs activated by GA-AG (Cartmell, et al., 2018). Bio-
chemical characterization of the proteins encoded by the
two associated genetic loci generated models for how
GA-AG is degraded by the bacterium. Briefly, the back-
bone is depolymerized by a series of exo-b-1,3-galac-
tosidases and the liberated backbone-associated side
chains (these enzymes accommodate side chains being
appended at the O6 position of the backbone galactose
units) are then removed by b-1,6-galactosidases, a-L-
rhamnosidases, b-D-glucuronidases and arabinosidases
through a hierarchical exo-mechanism. However, upon
extracellular degradation of GA-AG Ba. thetaiotaomicron
releases particular oligosaccharides into the media,
apparently because it does not possess the enzymatic
machinery to internalize and/or metabolize them (Cart-
mell, et al., 2018). The proposed AG degradation models
highlight the fact that to fully understand the metabolism
of these complex AG glycans, we need to explore the
nature of these released oligosaccharides as they may
feed other bacteria in the human gut where competition
for carbon resources is very high.
Bifidobacterium breve UCC2003 has been reported to
metabolize certain human milk oligosaccharides, as well
as various other dietary glycans, such starch, raffinose,
cellodextrins and galactooligosaccharides (Izumi, et al.,
2019; James, et al., 2019a; James, et al., 2019b; Ruiz-
Aceituno et al., 2020). However, B. breve is generally
not able to degrade and metabolize (complex)
polysaccharides (O’Connell Motherway, et al., 2018). It
is therefore believed that B. breve scavenges oligosac-
charides that are released from complex polysaccharides
by the action of a primary degrader. This cross-feeding
or syntrophic behaviour is known to occur between spe-
cies of the Bacteroidetes and Firmicutes phyla, although
members of the Bifidobacterium genus, which belongs to
the Actinobacteria phylum, may also engage in such
cross-feeding events (Turroni, et al., 2018; Singh, 2019;
Gutierrez and Garrido, 2019). With respect to AG utiliza-
tion, it has been shown that only three Bacteroides spe-
cies are able to utilize GA-AG. In co-culture (Degnan
and MacFarlane, 1995; Macfarlane, et al., 1995), these
three organisms (which for this reason were designated
as keystone organisms) enabled 17 other Bacteroides
species to grow on GA-AG through syntrophy by the uti-
lization of oligosaccharides that are generated at the cell
surface of the keystone bacteria.
In the current study, we demonstrate that growth of
Bacteroides cellulosilyticus on LW-AG releases rham-
nose and ß-1,3-galactooligosaccharides with a varying
degree of polymerization (DP) that can be metabolized
by a selected few bifidobacteria, including B. breve
UCC2003. The metabolic pathway that allows B. breve
UCC2003 to perform this cross-feeding behaviour is
identified and characterized.
Results
Cross-feeding between Bacteroides cellulosilyticus DSM
14838 (Baccell) and various Bifidobacterium species
In order to assess possible cross-feeding behaviour
between Baccell and Bifidobacterium strains, we initially
selected the prototype strain B. breve UCC2003 as a
candidate to determine if it could metabolize the
oligosaccharides released by Baccell when grown on
LW-AG, as previously established (Cartmell, et al.,
2018). For this purpose, we performed a cross-feeding
experiment where B. breve UCC2003 was grown on its
own or in conjunction with Baccell, a so-called keystone
microorganism capable of metabolizing AGs (Cartmell,
et al., 2018). In this experimental design, we counted the
colony-forming units (CFU) of each taxa by selection on
specific growth media and antibiotics. For example, we
used brain heart infusion (BHI) medium supplemented
with haematin when we assessed Bacteroides CFU,
while for bifidobacterial species, we selected on Rein-
forced Clostridium Media medium (see Experimental pro-
cedures section). Figure 1A shows the CFU-based
growth profile of Baccell on glucose and intact LW-AG,
confirming that this bacterium is able to metabolize the
latter glycan, as a result of which a monosaccharide and
certain oligosaccharides are released into the growth
medium as shown in Fig. 1B. The most abundant among
ª 2020 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.
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Fig. 1. Growth of Bacteroides cellulosyliticus (Baccell) and several bifidobacterial species. A. Growth curves of Baccell on glucose and LW-AG.
B. HPLC of the supernatant of Baccell grown on LW-AG where G2 is b-1,3-galactobiose and G3, b-1,3-galactotriose. C. Colony-forming units
(CFU) of B. breve UCC2003 for its co-culture with Baccell on glucose and LW-AG. D. CFU of B. longum subsp. infantis ATCC15697 for its co-
culture with Baccell on glucose and LW-AG. E. CFU of B. breve JCM7017 for its co-culture with Baccell on glucose and LW-AG. F. CFU of
B. bifidum LMG13195 for its co-culture with Baccell on glucose and LW-AG. G. CFU of B. longum subsp. longum NCIMB8809 for its co-culture
with Baccell on glucose and LW-AG. All experiments were made in triplicate and the mean  standard deviation is displayed.
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these released oligosaccharides were shown to be
rhamnose, 1,3-galactobiose and 1,3-galactotriose, as
identified by HPAEC-PAD (Fig. 1B). B. breve UCC2003
is unable to grow on intact LW-AG (Fig. 1C), whereas
co-cultivation experiments of Baccell and B. breve
UCC2003 on LW-AG as a sole carbon source showed
that the latter strain is able to grow (Fig. 1C), thus clearly
demonstrating cross-feeding behaviour. B. breve
UCC2003 is presumed to avail of some of the released
carbohydrates, with the observed growth apparently due
to metabolism of b-1,3-galactobiose and b-1,3-galac-
totriose, rather than rhamnose, which does not appear to
be a growth substrate for B. breve UCC2003 (Fig. 1B).
In the same way as described for B. breve UCC2003,
we performed cross-feeding experiments between Bac-
cell and B. breve JCM7017, B. longum subsp. longum
NCIMB8809, B. longum subsp. infantis ATCC15697 and
B. bifidum LMG13195. As shown in Fig. 1, only
B. longum subsp. infantis ATCC15697 is able to grow in
conjunction with Baccell on LW-AG (Fig. 1C, D). In con-
trast, B. breve JCM7017 (Fig. 1E), B. bifidum
LMG13195 (Fig. 1F) and B. longum subsp. longum
NCIMB8809 (Fig. 1G) lack this syntrophic ability. As we
will show below, this inability is linked to the presence or
absence of the bga cluster.
Identification and sequence analysis of BgaA
In order to identify the gene or genes that allow certain
bifidobacteria to cross-feed on the released AG-derived
oligosaccharides (Fig. 1), we selected the genome of
B. breve UCC2003 to look for b-galactosidase-encoding
genes. Through nucleotide sequence analysis of putative
genes, we identified bgaA (corresponding to locus tag
Bbr_0285) on the genome of B. breve UCC2003 as a
gene encoding a potential exo-b-galactosidase. BgaA is
predicted to encode a 606 residue protein containing a
catalytic domain from residues 18 (Aspartic acid) to iso-
leucine 461 resembling members of the glycoside hydro-
lase family 2 (GH2). The BgaA-encoding gene is part of
a three-gene cluster in B. breve UCC2003 (Fig. S1A): (i)
bgaA, encoding the aforementioned GH2 member BgaA,
(ii) bgaR, specifying a transcriptional regulator of the
LacI family (corresponding to locus tag Bbr_0283) and
(iii) a gene predicted to encoded a sugar symporter (cor-
responding to locus tag Bbr_0284, designated here as
bgaB). The presence or absence of (homologs) of the
cluster in the tested strains for cross-feeding was shown
to correspond with their syntrophic ability/inability (see
below for a full analysis of the prevalence of the bga
gene cluster in bifidobacterial genomes).
In order to enzymatically characterize the bgaA gene
product, we cloned bgaA and overexpressed and puri-
fied its gene product in Escherichia coli BL21 (DE3), see
Experimental procedures section, obtaining a yield of
approximately 20 mg l1 of purified BgaA. We performed
enzymatic assays to assess the catalytic action of this
protein on several polysaccharides (Fig. S1B), including
pectin b-galactan, in which the backbone glycan is b-1,4-
linked, type I AG from potato (where the galactan linkage
is also b-1,4), b-1,3-galactan and type II AG, which con-
tains b-1,3/1,6-linkages in the galactan backbone.
In addition, we performed enzyme activity reactions
with particular disaccharides as potential substrates for
BgaA, including b-D-galactopyranosyl-4-D-glucopyranose
(lactose), b-D-galactopyranosyl-4-N-acetyl-D-glucosamine
(LacNAc), b-D-galactopyranosyl-3-N-acetyl-D-glucosamine
(lacto-N-biose I), b-D-galactopyranosyl-3-D-galactopyra-
nose (b-D-1,3-galactobiose), b-D-galactopyranosyl-4-D-
galactopyranose (b-D-1,4-galactobiose), b-D-galactopyra-
nosyl-6-D-galactopyranose (b-D-1,6-galactobiose) and b-D-
(b-D-3-O-Galactopyranosyl)-galactopyranosyl-4-D-glucopyra-
nose (3-galactosyllactose) (Table 1 and Fig. S1C).
These assays revealed that of the tested substrates puri-
fied BgaA only exhibits hydrolytic activity towards b-D-
1,3-galactobiose, indicating that this protein possesses
very specific activity with a kcat/Km of 32 580  1673 M-
1 min-1. Figure 2A,B show the TLC and HPLC results for
these enzymatic reactions.
Enzyme characterization: Mode of action on b-1,3-
galactooligosaccharides
To elucidate the enzyme specificity and the number of
subsites in the active site of BgaA, we performed enzy-
matic assays with several 1,3-linked galactooligosaccha-
rides, including b-D-1,3-galactobiose, b-D-1,3-galactotriose,
b-D-1,3-galactotetraose and the human milk oligosaccha-
ride 3’-galactosyllactose (Fig. 2C,D). BgaA was shown to
be active on b-1,3-galactooligosaccharides with a DP
from 2 to 3 with a similar specific activity for both
oligosaccharides, whereas no activity was observed for
related substrates with a DP of four or higher (Table 1).
Table 1. Enzyme activity of BgaA with different galactooligosaccha-
rides.
Substrate
kcat/Km
(M-1 min-1)
1,3-G2 32 580  1673
1,3-G3 28 954  1002
1,3-G4 Inactive
3-galactosyllactose 3030  149
1,4-G2 Inactive
1,6-G2 Inactive
Lactose Inactive
LacNAc Inactive
Lacto-N-biose I Inactive
ª 2020 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.
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This implies that BgaA harbours three subsites within its
active site (1, +1 and + 2). Regarding the + 2 subsite,
when 3’-galactosyllactose was tested as a substrate, in
which the corresponding monosaccharide and linkage are
b-1,4-galactose attached to glucose, the observed activity
was decreased by ~ 10 fold, supporting the enzyme’s
specificity for b-1,3-galactose attached to galactose.
Together, our findings clearly show that BgaA exhibits
very high hydrolytic specificity towards short b-1,3-galac-
tooligosaccharides.
pH profile and metal-dependent activity for BgaA
In order to optimize the enzymatic conditions for the
assays, we performed reactions to assess the beha-
viour of the enzyme at varying pH values (Fig. S2A).
Specific activity of BgaA as a function of pH showed a
typical bell shape with maximum activity at pH 7.0. This
activity drastically decreased when the pH was above
7.5 and decreased when assays were performed below
pH 6.0.
In addition to the pH profile, we performed additional
enzymatic assays to determine if BgaA activity is metal-
dependent. For this purpose, we first treated the enzyme
with EDTA in excess to remove putative metal ions from
its active site and perform assays with this EDTA-treated
enzyme (Fig. S2B). BgaA was shown to lose all activity
following treatment with EDTA, indeed consistent with a
metal-dependent activity. This activity was recovered
when we removed the EDTA from the enzyme and
added Mg+2 to the reaction, confirming that BgaA is an
Mg+2-dependent galactosidase. Enzymatic activity of
EDTA-treated BgaA was not recovered when the assays
were performed with Ca+2, Mn+2 or Zn+2 (Fig. S2B).
Active site comparison with other GH2 enzymes
Based on the enzyme characterization and specificity
determination, to assess structural aspects of BgaA
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Fig. 2. Enzymatic assays of BgaA with different disaccharides, trisaccharides and tetrasaccharides. The experimental conditions were as fol-
lows: 20 mM sodium phosphate buffer pH 7.0, [S]0 = 1 mM and [E]0 = 1 µM. A. TLC. 1 = b-D-1,3-galactobiose, 2 = b-D-1,3-galacto-
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circle = galactose standard. B. HPLC of b-D-1,3-galactobiose + BgaA. C. HPLC of the enzymatic assays of BgaA with b-D-1,3-galactooligosac-
charides. D. HPLC of the enzymatic assays of BgaA with 3-galactosyllactose.
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including its active site, we made several unsuccessful
attempts to crystallize the molecule to obtain its 3D-
structure. As an alternative, since BgaA exhibits 25%
amino acid similarity to a b-galactosidase from E. coli
(LacZ, database code 1JYN), we used this 1JYN struc-
ture for the inactive mutant of LacZ in complex with lac-
tose as a template to model the BgaA structure. The
conserved residues in the active site of BgaA are shown
in Fig. S3A in green and the residues for LacZ in blue.
In LacZ, the nucleophile E537 has been mutated to an
inactive glutamine to obtain the complex with lactose.
The nucleophilic residue (E514 in BgaA and E537 in
LacZ) is conserved in both proteins and in the same ori-
entation to mount the nucleophilic attack with a 7.1 A
distance with the glycosidic bond in lactose (Fig. S3A).
However, the predicted catalytic donor (D421 in BgaA) is
not conserved in these two proteins being E461 in LacZ.
In addition, D421 is in a different orientation to E461 in
LacZ having a distance of 4.3A.
To understand the substrate specificity of BgaA
towards 1,3-b-galactooligosaccharides, we compared the
surface structure of this protein with that of LacZ. LacZ
contains a deep pocket to perfectly accommodate
lactose and other galactooligosaccharides, as outlined in
Fig. S3B, in which the catalytic residues are highlighted
in magenta. However, this pocket is not present in BgaA
showing clashes in the active site when we model lac-
tose (Fig. S3C). This effect would explain the specific
activity of BgaA for b-1,3-linkages rather than b-1,4 or b-
1,6 glycosidic bonds.
Disruption of genes in the bga cluster in B. breve
UCC2003
In order to confirm the expected biological role and
importance of Bbr_0284 (BgaB) and BgaA in the meta-
bolism and cross-feeding on short-chain b-1,3-galac-
tooligosaccharides, we obtained genetic knockouts for
the corresponding two genes bgaB and bgaA (see
Experimental procedures), and then performed growth
curves employing wild-type B. breve UCC2003 and the,
respective, knockout mutants BbrUCC2003D0284 and
BbrUCC2003D0285 (Fig. 3A–C). The wild-type strain
UCC2003 grew well in medium containing with glucose
(positive control), galactobiose or galactotriose as its
sole carbon source, but was unable to grow in a medium
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Fig. 3. Growth curves of B. breve UCC2003 or its derivatives with b-D-1,3-oligosaccharides. A. Wild type. B. B. breve BbrUCC2003D0284. C.
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containing galactotetraose as the sole carbon source
(Fig. 3A). Both mutants grew equally well on glucose as
the WT UCC2003 strain, yet mutant BbrUCC2003D0284
(Fig. 3B) was unable to grow on galactobiose or galac-
totriose, while growth of mutant BbrUCC2003D0285 on
these two galactooligosaccharides was noticeably
affected in that growth rate was reduced (Fig. 3C). The
latter observation is likely due to the presence of one or
more additional b-galactosidases in B. breve UCC2003
that are able to degrade these b-1,3-galactooligosaccha-
rides, though with an apparently lower specificity.
Indeed, at least eight predicted b-galactosidases are
encoded in B. breve UCC2003, of which some have
been characterized and shown to have overlapping
specificities (O’Connell Motherway, et al., 2010; O’Con-
nell Motherway, et al., 2012; Ambrogi, et al., 2019;
James, et al., 2019a; James, et al., 2019b). This result
indicates that the gene bgaB encodes a transport sys-
tem that is highly specific for b-1,3-galactobiose and b-
1,3-galactotriose (Fig. 3B), in the absence of which the
strain is unable to internalize and consequently metabo-
lize these saccharidic substrates.
In order to determine to what extent the observed syn-
trophic activities of B. breve UCC2003, described in
Fig. 1A–C, are dependent on the bga cluster, we cul-
tured B. breve mutant BbrUCC2003D0284 with Baccell
together in a medium containing LW-AG. Under these
conditions, the B. breve mutant was unable to grow,
apparently because of its inability to import the released
b-1,3-galactooligosaccharides (Fig. 3D).
Analysis of metabolites generated by b-1,3-
galactooligosaccharide metabolism
Human gut microbiota interacts with the host releasing
specific short-chain fatty acids (SCFAs), mainly acetate,
butyrate and propionate (Wang, et al., 2019). In this
sense, the determination of released SCFAs will provide
insights into any benefit that the host may derive from
such microbial syntrophy. LC/MS of the supernatants
generated during the co-cultivation of Baccell and
B. breve UCC2003 is shown in Table 2. This metabolite
profile shows that Baccell mainly produces succinate
and acetate. This fermentation end-product profile has
previously been observed for this species when it metab-
olizes other carbohydrates like inulin or fructan (Falony,
et al., 2009). In the case of LW-AG, the monoculture of
Baccell results in acetate production due to fermentation
of carbohydrates that originate from LW-AG. When we
co-cultivated Baccell and B. breve UCC2003, a clear
increase of acetate levels was observed when compared
to that for Baccell mono-cultivation, an observation which
indicates that the overall SCFA production increases due
to syntrophic behaviour.
Butyrate production during co-cultivation appeared to
be similar irrespective as to whether Baccell was grown
on LW-AG in monoculture or in conjunction with B. breve
UCC2003, confirming the known inability of B. breve
UCC2003 to produce this SCFA. Furthermore, the co-
cultivation caused production of lactate and formate as
additional metabolic end products, both of which can be
exclusively attributed to B. breve UCC2003 metabolism
(Table 2) (Watson, et al., 2013; McLaughlin, et al.,
2015). In conclusion, the observed syntrophic interaction
leads to higher and more varied levels of SCFAs and
the production of lactic acid.
Prevalence of the bga cluster among bifidobacteria
In order to investigate the prevalence of the bga cluster
in several B. breve genomes, we performed a BLASTP-
mediated search for homologues of bgaB/bgaA in
B. breve and revealed that this cluster is present in just
a few representatives of this species, with positive
matches in only four representatives out of the 89
B. breve genomes accessible in the NCBI public data-
base (Fig. 4). Interestingly, in B. breve strains that do
not harbour the bga cluster, this genetic region is
replaced by a carbohydrate utilization cluster of unknown
specificity and predicted to encode an ABC-type uptake
system, an a-galactosidase (glycoside hydrolase family
36) and an AraC-type transcriptional regulator (Fig. S1A
provides a comparative genomic analysis of B. breve
strains UCC2003 and JCM 7017).
When extending this comparison to other members of
the genus Bifidobacterium, our analysis revealed that
homologues of the bgaB/bgaA cluster are observed in
B. longum, with positive matches in 16 out of the 182
publicly available B. longum genomes. Down to the sub-
species level, our analysis showed that of the 16 positive
strains carrying this cluster, at least half are deposited in
NCBI as members of B. longum subsp. infantis (the
other half being generically referred as B. longum).
Taken together, our analysis shows that the ability of
degrading b-1,3-galactooligosaccharides represents an
Table 2. Millimolar (mM) concentration of the metabolites generated
in the cell-free supernatant of MM + 1% LW-AG, following 24 h
incubation with Baccell and B. breve UCC2003.
Succinate
(mM)
Acetate
(mM)
Lactate
(mM)
Formate
(mM)
No inoculum 1% LW-AG ND 1.2 2.1 0.9
Baccell 1% LW-AG 60 24 ND ND
B. breve UCC2003 1%
LW-AG
ND 1.4 1.9 1.1
Baccell, B. breve
UCC2003 1% LW-AG
68 94 6.0 6.9
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infrequently occurring feature in Bifidobacterium, being
confined to just a few members of B. breve and
B. longum subsp. infantis (Fig. 4).
This result is also supported by our previous observa-
tion of the distribution of the b-galactosidase-encoding
genes from B. breve UCC2003 across 34 representa-
tives of B. breve, B. longum and B. bifidum (Ambrogi,
et al., 2019). Also in this case, the presence of the BgaA
b-galactosidase Bbr_0285 was only detected in B. breve
UCC2003 and B. longum subsp. infantis ATCC 15697
(Ambrogi, et al., 2019), thus confirming our current
observations, which are now extended to a much larger
data set (Fig. 4). The finding that the genome of
B. longum subsp. infantis ATCC 15697 contains gene
homologs of the bga cluster is in agreement with its
observed cross-feeding ability (see above). Conversely,
the other bifidobacteria tested, that is B. breve
JCM7017, and the B. longum subsp. longum and B. bi-
fidum strains do not contain the bga cluster and indeed
were shown to be unable to cross-feed.
Discussion
Syntrophic interactions between species of two genera
have been described for various glycans including fruc-
tan (Falony, et al., 2009), wheat arabinoxylan (Rogowski,
et al., 2015) and AG (Degnan and Macfarlane, 1995;
Macfarlane, et al., 1995). For example, Bacteroides ova-
tus supports growth of Bifidobacterium adolescentis
strain ATCC15703 because this Bifidobacterium strain
can only utilize linear arabino-xylo-oligosaccharides
released by Ba. ovatus when cultivated on complex
xylan (Rogowski, et al., 2015). Therefore, growth of bifi-
dobacterial strains on highly decorated xylans, like those
found in corn, depends on an extensive repertoire of
enzyme families including an GH98 endo-xylanase of
Ba. ovatus ATCC8483.
In the current study, we describe cross-feeding
between Ba. cellulosilyticus (Baccell) and B. breve
UCC2003. B. breve is not able to use intact AGs as a
carbon source because it lacks the catalytic apparatus to
degrade this large and complex polysaccharide. In con-
trast, Baccell can utilize this glycan as a sole carbon
resource, while also releasing certain mono- and
oligosaccharides into the media that then become avail-
able for growth of other commensal bacteria in the gut. In
our study, we showed the ability of B. breve UCC2003 to
use short-chain b-1,3-galactooligosaccharides, liberated
by Baccell. The B. breve UCC2003 bga gene cluster
allowing this was identified and was shown to be involved
in the binding, incorporation and degradation of two par-
ticular b-1,3-galactooligosaccharides. BgaA, which is a
member of GH2, is involved in this catabolic process and
is very specific to exclusively accommodate b-1,3-galac-
tobiose and b-1,3-galactotriose in the active site. To date,
only a small number of b-galactosidases belonging to
GH2 have been described to specifically utilize these
oligosaccharides in Bifidobacterium spp. (Yi, et al., 2011;
Viborgh, et al., 2014; Arreola, et al., 2014). Bifidobac-
terium spp. are excellent lactose and galacto-oligosac-
charide degraders, with some species also capable of
metabolizing specific human milk oligosaccharides
(James, et al., 2019a; James, et al., 2019b). Only a small
number of bifidobacterial species are known to be able to
metabolize AG (Crociani, et al., 1994; Fujita, et al.,
2019). For example, B. longum subsp. longum has been
described to ferment gum arabic, a type II AG frequently
added to foods as an emulsifier (Crociani, et al., 1994;
Cartmell, et al., 2018).
Bifidobacterium  species B
br
_0
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4
B
br
_0
28
5
Fr
eq
ue
nc
y
Genomes in database (0-200) % SIMILARITY (BLASTP)
1 Bifidobacterium bifidum 100
2 Bifidobacterium breve 4/89 95
3 Bifidobacterium kashiwanohense 90
4 Bifidobacterium pseudocatenulatum 85
5 Bifidobacterium adolescentis 80
6 Bifidobacterium angulatum <79
7 Bifidobacterium catenulatum
8 Bifidobacterium gallicum
9 Bifidobacterium longum spp. 16/182
10 Bifidobacterium stercoris
Fig. 4. Prevalence of the bga cluster in Bifidobacterium. Heat-map showing the BLASTP-mediated comparative analysis of BgaA/BgaB across
representatives of human-derived bifidobacteria. Gene products from the representative strain genomes of all known publicly available Bifi-
dobacterium species were scrutinized and the result of human-derived Bifidobacterium species with a significant homology of 80% iterative sim-
ilarity over 50% of protein length is represented in this matrix. Gene presence (yellow) and absence (blue) with a colour grading representing
the degree of sequence similarity at protein level are indicated, along with the frequency of occurrence of this cluster in each species and the
total number of genomes in each species.
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The specific activity of BgaA for particular b-1,3-galac-
tooligosaccharides is likely to be due to the structural
properties of its active site. We showed, through the
structural model for this protein, how b-1,4 and b-1,6-
galactooligosaccharides would sterically clash in the
active site of BgaA, when compared to other, less sub-
strate-specific galactosidases, which contain a loop that
prevents entrance of these b-1,3-oligosaccharides into
the active site. This loop is not present in BgaA, allowing
the entrance of these particular oligosaccharides, yet
clashing with 1,4/1,6-linkages, including lactose, which is
not a substrate for BgaA. However, as this is only a pre-
dicted structural model, a crystal structure of this protein
is required, which may then allow protein engineering of
BgaA.
In the current study, we solve the molecular interac-
tions between Baccell and B. breve UCC2003 in LW-AG
metabolism, showing that Baccell mainly released rham-
nose, b-1,3-galactobiose and b-1,3-galactotriose in the
media (Fig. 1B). B. breve UCC2003 internalizes these
galactooligosaccharides through BgaB into the cyto-
plasm, though it appears unable to incorporate and/or
metabolize the released rhamnose. Following internaliza-
tion of the two b-1,3-galactooligosaccharides, they are
hydrolysed by BgaA into galactose (Fig. 5). Rhamnose
may be used by other gut commensals, for example
E. coli or perhaps other Bacteroides species, presenting
additional syntrophic interactions (E. coli producing 1,2-
propanediol, which in turn can be used by for example
Eubacterium hallii to be converted in propionic acid)
(Belenguer, et al., 2006; Engels, et al., 2016; Matsubara,
et al., 2016). Therefore, the ecological complexities of
LW-AG metabolism in the gut are likely to be more elab-
orate than what we have demonstrated here (Fig. 5).
Remarkably, the bga cluster is not conserved among
analysed members of the Bifidobacterium genus (Fig. 4).
The strain-specific presence of certain carbohydrate
metabolic clusters has previously been shown to impact
on colonization and persistence of particular strains in
the gut (Maldonado-Gomez, et al., 2016). Therefore,
strains having the bga cluster as presented in this paper,
and the associated ability to metabolize short-chain b-
1,3-GOS, will provide an ecological advantage if the diet
of the host contains AGs and if the microbiota houses
keystone Bacteroides spp., such as Baccell, to provide
initial breakdown and release the GOS. Baccell has
been shown as a keystone organism in AG metabolism,
enabling other gut microbiota species to grow in this
complex glycan (Cartmell, et al., 2018).
In addition to the cross-feeding experiments and the
biochemical analysis, we investigated the means by
which the observed Baccell and B. breve UCC2003
1,3
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Fig. 5. Schematic view of cross-feeding between Baccell and B. breve UCC2003 when grown on LW-AG.
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interactions could benefit the host through SCFA produc-
tion. Acidification of the colon has been shown to supress
growth of pathogens, while SCFAs, which are rapidly
absorbed into by the colonic mucosa, can supply energy
to the host (McLaughlin, et al., 2015; Connors, et al.,
2019). Cross-feeding interactions between Baccell and
Bifidobacterium when metabolizing LW-AG, mainly leads
in succinate and acetate production (Table 2). Acetate
promotes the gastrointestinal motility, while succinate has
been linked with protection during colonization by patho-
gens. Interestingly, Bacteroides was recently shown to
mediate colonization resistance to Salmonella typhimur-
ium via production of propionate, which relies on succi-
nate as an intermediate (Connors, et al., 2019).
Finally, from a prebiotic perspective it seems that this
b-1,3-GOS represents a very species and strain-specific
carbohydrate (though we of course do not know if other
gut commensal may grow on it), but it may be a very
effective and highly specific synbiotic if used in combina-
tion with a probiotic that has the ability to metabolize
these GOS fractions. Further studies will be required to
investigate if other Bifidobacterium spp. or other gut
commensals are able to metabolize these b-galac-
tooligosaccharides and how this may impact on other
gut community members and, consequently and impor-
tantly, host health.
Experimental procedures
Bacterial strains, plasmids and culture conditions
Bacterial strains and plasmids used in this study are
listed in Table S1. Where appropriate, growth media
contained erythromycin (Em; 100 lg ml-1) and/or kana-
mycin (Kan; 50 lg ml-1). Bacteroides strains were rou-
tinely cultured in brain heart infusion (BHI) media
supplemented with 1% haematin. Bifidobacterial strains
were routinely cultured in either de Man Rogosa and
Sharpe medium (MRS medium; Difco, BD, Le Pont de
Claix, France) supplemented with 0.05% cysteine-HCl or
reinforced clostridial medium (RCM; Oxoid Ltd., Bas-
ingstoke, UK). Bifidobacterial strains were incubated
under anaerobic conditions in a modular atmosphere-
controlled system (Davidson and Hardy, Belfast, Ireland)
at 37°C. Escherichia coli strains EC101 and TUNER
(DE3) were cultured in Luria-Bertani (LB) broth (Sam-
brook and Maniatis, 1989), containing Kan, and without
antibiotics, respectively, at 37°C with agitation. Recombi-
nant E. coli EC101 cells containing (derivatives of)
pFREM-ORI28 were selected on LB agar containing Em
and Kan, and recombinant E. coli TUNER cells contain-
ing (derivatives of) pET28b were selected on LB agar
containing Kanamycin. Mutants of B. breve UCC2003
generated through the genomic integration of pFREM-
ORI28 were selected on reinforced clostridial agar (RCA;
Oxoid Ltd.), containing Em (see below for further details
on the mutation strategy). For protein overexpression,
recombinant E. coli TUNER strains were cultured in NZY
auto-inducible LB broth (NZYTech, Lisbon, Portugal).
Reagents
All disaccharides tested in this study were purchased
from Dextra UK (Reading, UK) or Carbosynth (Reading,
UK) (Fig. S1C). L-Rhamnose, L-arabinose, D-Galactose,
D-glucose and Larch Wood Arabinogalactan (LW-AGP)
were purchased from Sigma (Haverhill, UK). Luria-Ber-
tani (LB) growth medium was purchased from Forme-
dium (Norfolk, UK), reinforced clostridial agar from Oxoid
Ltd. and brain heart infusion from Sigma. All reagents
were of analytical grade.
Cloning and expression of recombinant proteins
The gene associated with locus tag Bbr_0285 (accession
number ABE94991, and designated here as bgaA) was
amplified from B. breve UCC2003 using its genomic
DNA as template and cloned into pET28a (Novagen,
Watford, UK) using NheI and HindIII restriction sites for
production and purification of its encoded product facili-
tated by the incorporation with an N-terminal His6 tag
(Table S1). For this, E. coli TOP10 cells (ThermoFisher
Scientific) were used. The recombinant construct was
sequenced (Eurofins Genomics, Ebersberg, Germany) to
verify its genetic integrity and then used to transform
E. coli BL21 (DE3) expression cells (ThermoFisher Sci-
entific). Cells were cultured in Luria-Bertani (LB) medium
containing with 10 µg ml1 kanamycin antibiotic to mid-
log phase (A600nm of ~ 0.6). Protein expression was
induced by adding 0.1 mM isopropyl b-D-1-thiogalactopy-
ranoside (IPTG) to cells followed by growth overnight at
16°C. The next day, cells were harvested by centrifuga-
tion (4000 g) and re-suspended in Talon buffer (20 mM
Tris/HCl pH 8.0 plus 100 mM NaCl). Re-suspended cells
were disrupted and centrifuged (16 000 g) for 20 min at
4°C, after which BgaA was purified from the resulting
cell-free extract by immobilized metal affinity chromatog-
raphy (IMAC) using TalonTM, a cobalt-based matrix. In
the process, the cell-free extract (CFE) was loaded on a
column containing the Talon resin and then washed with
Talon buffer. Another wash was performed with Talon
buffer containing 10 mM imidazole followed by recombi-
nant protein elution with 100 mM imidazole. Purified pro-
teins were then exchanged into a buffer of choice by
standard dialysis.
Enzyme assays
All enzyme assays, unless otherwise stated, were car-
ried out in 20 mM sodium phosphate buffer, pH 7.0,
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containing 150 mM NaCl and performed in triplicate.
Assays were carried out at 37°C employing 1 µM BgaA
in the presence of 150 µM substrate. Aliquots were
taken over a 16 h time course, and samples and prod-
ucts were assessed by TLC and high pressure anion
exchange chromatography (HPAEC) with pulsed amper-
ometric detection (PAD). Sugars (mono and short
oligosaccharides) were separated on a Carbopac PA1
guard and analytical column in an isocratic program of
100 mM sodium hydroxide during 40 min and then with
a 100% linear gradient of 500 mM sodium acetate over
60 min. Sugars were detected using the carbohydrate
standard quad waveform for electrochemical detection at
a gold working electrode with an Ag/AgCl pH reference
electrode. Kinetic parameters were determined using the
D-galactose detection kit from Megazyme, measuring the
release of galactose by absorbance of 340 nm. To deter-
mine kinetic parameters, 100 nM of the appropriate
enzyme was assayed against varying concentrations of
oligosaccharides between 0.1 and 1 mM. D-galactose
release was measured, and the values were plotted
using linear regression giving kcat/Km as the slope of the
line.
Nucleotide sequence analysis
Sequence data were obtained from the Artemis-medi-
ated (Rutherford, et al., 2000) genome annotations of
B. breve UCC2003 (O’Connell Motherway, et al., 2011).
Database searches were performed using non-redundant
sequences accessible at the National Center for Biotech-
nology Information (NCBI) (http://www.ncbi.nlm.nih.gov)
using the basic local alignment search tool (BLAST)
(Altschul, et al., 1990; Altschul, et al., 1997). Sequences
were verified and analysed using the SeqMan and Seq-
Builder programs of the DNAStar software package (ver-
sion 10.1.2; DNAStar, Madison, WI, USA). Gene product
(protein) localization and signal peptide predictions were
made using the TMHMM, v. 2.0 and SignalP, v. 4.1
(Petersen, et al., 2011) servers, respectively, available at
http://www.cbs.dtu.dk/.
DNA Manipulations
Chromosomal DNA was isolated from B. breve
UCC2003 as previously described (O’Riordan and
Fitzferald, 1999). Plasmid DNA was isolated from E. coli
using the Roche High Pure Plasmid Isolation kit (Roche
Diagnostics, Basel, Switzerland). An initial lysis step was
performed using 30 mg ml1 of lysozyme for 30 min at
37°C prior to plasmid isolation from B. breve. DNA
manipulations were essentially performed as described
previously (Sambrook and Maniatis, 1989). All restriction
enzymes and T4 DNA ligase were used according to the
supplier’s instructions (Roche Diagnostics). Synthetic
single-stranded oligonucleotide primers used in this
study (Table S1) were synthesized by Eurofins. Stan-
dard PCRs were performed using Phusion Green Hot
Start II High-Fidelity PCR Master Mix (Thermo Scientific,
Waltham, MA, USA) in a Life Technologies Proflex PCR
System (Thermo Scientific). PCR products were visual-
ized by staining using SYBR Safe DNA gel stain follow-
ing agarose gel electrophoresis (1% agarose). B. breve
colony PCR reactions were performed as described pre-
viously (O’Connell Motherway, et al., 2009). PCR frag-
ments were purified using the Roche high Pure PCR
purification kit (Roche Diagnostics). Plasmid DNA was
isolated using the Roche High Pure Plasmid Isolation kit
(Roche Diagnostics). Plasmid DNA was introduced into
E. coli by electroporation as described previously (Sam-
brook and Maniatis, 1989). B. breve UCC2003 was
transformed by electroporation according to a previously
published protocol (Maze, et al., 2007). The correct ori-
entation and integrity of all plasmid constructs (see also
below) were verified by DNA sequencing, performed at
Eurofins.
Construction of B. breve UCC2003 insertion mutants
Internal fragments of Bbr_0284 (designated here as
bgaB) (fragment size was 617 bp, representing codon
numbers 134 through to 340 of the 482 codons of this
gene), and of bgaA (fragment size was 579 bp, repre-
senting codon numbers 197 through to 390 of the 607
codons of this gene), were amplified by PCR using
B. breve UCC2003 chromosomal DNA as a template
and primer pairs IM284F and IM284R, or IM285F and
IM285R, respectively (Table S2) (Fig. S1A). The inser-
tion mutants were constructed using an adaptation of a
previously developed method (O’Connell Motherway,
et al., 2009). In short, a non-replicating plasmid was inte-
grated into the genome by homologous recombination,
being guided by a sequence identical to that of an inter-
nal portion of the targeted gene. Successful integration
of the plasmid was ensured and retained using a select-
able marker of antibiotic resistance. The modification to
the existing protocol was the use of an alternative plas-
mid with a different antibiotic resistance marker. Instead
of pORI19 with an added tetracycline resistance marker,
a modified version of this plasmid with an erythromycin
resistance marker (EmR) (Bottacini, et al., 2018) was
used, designated pFREM28 (E.C. Hoedt, F. Bottacini, N.
Cash, R.S. Bongers, K. van Limpt, K. Ben Amor, J. Knol,
J. MacSharry and D. van Sinderen, in preparation). Site-
specific recombination of potential Em-resistant mutant
isolates was confirmed by colony PCR using primer
combinations EmRFw and EmRRv to verify EmR integra-
tion, and primers 284confirm1 and 284confirm2, and
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285confirm1 and 285confirm2 (positioned upstream of
the selected internal fragments of bgaB and bgaA,
respectively) in combination with primer EmRRv to con-
firm integration at the correct chromosomal location
(Table S2). The data for confirmation of gene deletion
are shown in supporting information.
Cross-feeding and competition assays
Before co-culture, Ba. cellulosilyticus DSM 14838 (Bac-
cell) was grown in BHI and washed in PBS. Monocul-
tures of bifidobacterial strains were grown on Reinforced
Clostridium Media (Oxoid) and washed in PBS before
being used to inoculate Minimal Media (MM) containing
1% LW-AG (Cartmell, et al., 2018). Co-cultures were
grown in inoculate Minimal Media containing 1% LW-AG
in triplicate. Samples of 0.5 ml were taken at regular
intervals during growth, which were serially diluted and
plated onto brain–heart infusion (Sigma-Aldrich) with
agar and porcine haematin for determination of total
CFUs per millilitre of the culture (Bacteroides) and onto
Reinforced Clostridium Media with 0.05% cysteine (for
wild-type bifidobacterial strains) and with 100 µg ml1
erythromycin (for insertional mutants in B. breve
UCC2003). Each monoculture of Bacteroides or Bifi-
dobacterium was also plated for determination of CFUs
per millilitre at intervals during the growth.
Sugars (mixed type of oligosaccharides from growth
media) were separated on a Carbopac PA200 guard and
analytical column in an isocratic program of 100 mM
sodium hydroxide during 40 min and then with a 100%
linear gradient of 500 mM sodium acetate over a 60 min
period. Sugars were detected using the carbohydrate
standard quad waveform for electrochemical detection at
a gold working electrode with an Ag/AgCl pH reference
electrode.
Comparative bioinformatic analysis
Protein coding sequences derived from a total of 592
representative strains from 66 bifidobacterial species
were downloaded from the NCBI Reference Sequence
collection Refseq (ftp://ftp.ncbi.nlm.nih.gov/genomes/
refseq/bacteria) and used as input for the comparative
analysis. The occurrence of bgaA and bgaB homologues
(or their encoded protein products) across members of
the Bifidobacterium genus was performed using BLASTP
alignments (Altschul, et al., 1997) against databases
containing the Open Reading Frames (ORFs) of each
bifidobacterial species. The identification of proteins
homologous to BgaA and BgaB across Bifidobacterium
was determined using cut-off values of 80% of similarity
across 50% of protein length and a 0.0001 e-value as a
significance. The result of the alignments was
represented in a presence/absence binary heat-map with
a colour gradient expressing the degree of sequence
similarity across bifidobacterial species, ordered by origin
of isolation. A bgaAB gene pair was defined as being
present in a given bifidobacterial genome when homo-
logues of the two genes were found co-located within
the same genomic region with an average similarity of at
least 80% at their deduced protein level.
Metabolite analysis by High-Performance Liquid
Chromatography (HPLC)
HPLC analysis was used to assess SCFA production by
(cross-feeding) Baccell and B. breve UCC2003. Growth
medium supernatants from stationary phase (co-)cultures
were filter sterilized (0.45 µM filter, Costart Spin-X col-
umn) and injected into an UltiMate BioRS Thermo
HPLC system (Thermo Fisher Scientific) with a refractive
index detector system. This system was used to identify
and calculate the production of acetate, lactate and buty-
rate as a result of carbohydrate fermentation. Concentra-
tions were calculated based on known standards. Non-
fermented medium containing LW-AG served as control.
An AccucoreTM C18 HPLC column was used and main-
tained at 65°C. Elution was performed for 25 min using
10 mM H2SO4 solution at a constant flow rate of
0.6 ml min1.
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